Antimicrobial Activity and Metalloprotease Inhibition of Hinokitiol-Related Compounds, the Constituents of Thujopsis dolabrata S. and Z. hondai MAK
γ-Thujaplicin, β-dolabrin and hinokitiol(β-thujaplicin), hinokitiol-related compounds isolated from the wood of Thujopsis dolabrata S. and Z. hondai MAK have antimicrobial activity. In particular, strong antibacterial activity of hinokitiol and β-dolabrin on Staphylococcus epidermidis IFO-12993 was...
Saved in:
Published in: | Biological & pharmaceutical bulletin Vol. 22; no. 9; pp. 990 - 993 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Tokyo
The Pharmaceutical Society of Japan
01-09-1999
Maruzen Japan Science and Technology Agency |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | γ-Thujaplicin, β-dolabrin and hinokitiol(β-thujaplicin), hinokitiol-related compounds isolated from the wood of Thujopsis dolabrata S. and Z. hondai MAK have antimicrobial activity. In particular, strong antibacterial activity of hinokitiol and β-dolabrin on Staphylococcus epidermidis IFO-12993 was found, with a minimum inhibitory concentration (MIC) of 0.2 μg/ml. This activity was higher than that of gentamicin, used as a positive control, and so the strong antibacterial activity of both compounds on this bacterium is of considerable interest. Of the three compounds, γ-thujaplicin showed the strongest antifungal activity and its MIC was found to be around 1.5 μg/ml. The three compounds also inhibited metalloproteases. The inhibitory activity of hinokitiol on carboxypeptidase A was especially strong, its 50%-inhibitory concentration (IC50) being 2.76×10-6 M. Considering that metaloproteases are involved in inflammation, the strong inhibitory activity of hinokitiol could be important. On the other hand, hinokitiol-acetate did not show any antimicrobial activity and metalloprotease inhibition, suggesting that at least part of the activity is due to metal chelation between the carbonyl group at C-1 and the hydroxyl group at C-2 in the tropolone skeleton. |
---|---|
AbstractList | Gamma-thujaplicin, beta-dolabrin and hinokitiol(beta-thujaplicin), hinokitiol-related compounds isolated from the wood of Thujopsis dolabrata S. and Z. hondai MAK have antimicrobial activity. In particular, strong antibacterial activity of hinokitiol and beta-dolabrin on Staphylococcus epidermidis IFO-12993 was found, with a minimum inhibitory concentration (MIC) of 0.2 microg/ml. This activity was higher than that of gentamicin, used as a positive control, and so the strong antibacterial activity of both compounds on this bacterium is of considerable interest. Of the three compounds, gamma-thujaplicin showed the strongest antifungal activity and its MIC was found to be around 1.5 microg/ml. The three compounds also inhibited metalloproteases. The inhibitory activity of hinokitiol on carboxypeptidase A was especially strong, its 50%-inhibitory concentration (IC50) being 2.76x10(-6) M. Considering that metalloproteases are involved in inflammation, the strong inhibitory activity of hinokitiol could be important. On the other hand, hinokitiol-acetate did not show any antimicrobial activity and metalloprotease inhibition, suggesting that at least part of the activity is due to metal chelation between the carbonyl group at C-1 and the hydroxyl group at C-2 in the tropolone skeleton. γ-Thujaplicin, β-dolabrin and hinokitiol(β-thujaplicin), hinokitiol-related compounds isolated from the wood of Thujopsis dolabrata S. and Z. hondai MAK have antimicrobial activity. In particular, strong antibacterial activity of hinokitiol and β-dolabrin on Staphylococcus epidermidis IFO-12993 was found, with a minimum inhibitory concentration (MIC) of 0.2 μg/ml. This activity was higher than that of gentamicin, used as a positive control, and so the strong antibacterial activity of both compounds on this bacterium is of considerable interest. Of the three compounds, γ-thujaplicin showed the strongest antifungal activity and its MIC was found to be around 1.5 μg/ml. The three compounds also inhibited metalloproteases. The inhibitory activity of hinokitiol on carboxypeptidase A was especially strong, its 50%-inhibitory concentration (IC50) being 2.76×10-6 M. Considering that metaloproteases are involved in inflammation, the strong inhibitory activity of hinokitiol could be important. On the other hand, hinokitiol-acetate did not show any antimicrobial activity and metalloprotease inhibition, suggesting that at least part of the activity is due to metal chelation between the carbonyl group at C-1 and the hydroxyl group at C-2 in the tropolone skeleton. |
Author | INAMORI, Yoshihiko ISHIDA, Nakao SHINOHARA, Sayo SAKAGAMI, Yoshikazu KUMEDA, Yuko MORITA, Yasuhiro TSUJIBO, Hiroshi OKABE, Toshihiro |
Author_xml | – sequence: 1 fullname: INAMORI, Yoshihiko – sequence: 2 fullname: SHINOHARA, Sayo – sequence: 3 fullname: TSUJIBO, Hiroshi – sequence: 4 fullname: OKABE, Toshihiro – sequence: 5 fullname: MORITA, Yasuhiro – sequence: 6 fullname: SAKAGAMI, Yoshikazu – sequence: 7 fullname: KUMEDA, Yuko – sequence: 8 fullname: ISHIDA, Nakao |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1993847$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10513629$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkU1v1DAQhi1URLeFCz8AWQJxQGTxR5yP42oFtKIVEuyJSzRxJsSL1w6xg9TfwR_G6a4K4jLWaJ6ZdzzvBTlz3iEhzzlbc5FX79qxXQuxrmv2iKy4zMtMCa7OyIrVvMoKrqpzchHCnjFWMiGfkHPOFJeFqFfk98ZFczB68q0BSzc6ml8m3lFwHb3FCNb6cfIRISC9doNpTTTeUd_TK-P8jyWz2Re0ELGjW38Y_ey68JbGAVPqQjRxRhfD0rEb5r0fgwm08xbaCSLQr-t7qW9rOnjXgaG3m09PyeMebMBnp_eS7D68322vspvPH6-3m5tMKyZipngrcihUUfUlVFBIJrpO6qrvUCjQqDUTDPuei1aWLReCI1SsZgow56yWl-T1cWz64M8ZQ2wOJmi0Fhz6OTQlq4SSSiXw5X_g3s-TS6s1PM_TjSVnZaLeHKl0yxAm7JtxMgeY7hrOmsWnJvnUCNEknxL84jRybg_Y_YMejUnAqxMAQYPtJ3DahL9cXcsqX0S3R2wfInzHhzpM0WiLi-SC3sseQ1J_qOoBpgad_AOharVo |
CitedBy_id | crossref_primary_10_1016_j_jspr_2008_08_001 crossref_primary_10_1038_s41419_019_1492_6 crossref_primary_10_1248_bpb_25_981 crossref_primary_10_1007_s00044_009_9174_z crossref_primary_10_1177_1203475417690306 crossref_primary_10_1016_S0277_5387_02_01064_1 crossref_primary_10_2492_inflammregen_32_137 crossref_primary_10_1021_acs_langmuir_5b03874 crossref_primary_10_1248_bpb_26_1487 crossref_primary_10_1303_aez_2004_699 crossref_primary_10_1248_bpb_24_299 crossref_primary_10_1515_HF_2006_004 crossref_primary_10_1039_C5DT00817D crossref_primary_10_4236_ajac_2017_85026 crossref_primary_10_1021_acsinfecdis_5b00017 crossref_primary_10_1016_j_ica_2008_02_061 crossref_primary_10_1246_cl_200966 crossref_primary_10_1016_S1349_0079_10_80007_6 crossref_primary_10_9721_KJFST_2012_44_1_114 crossref_primary_10_1016_j_archoralbio_2013_10_009 crossref_primary_10_1248_bpb_24_607 crossref_primary_10_1016_j_jff_2015_03_036 crossref_primary_10_1007_s12272_011_1218_5 crossref_primary_10_1016_j_bbrc_2006_01_015 crossref_primary_10_1292_jvms_68_373 crossref_primary_10_1111_1348_0421_12688 crossref_primary_10_1303_aez_2004_521 crossref_primary_10_1007_BF00771373 crossref_primary_10_1016_j_jinorgbio_2003_07_002 crossref_primary_10_1248_bpb_27_899 crossref_primary_10_1007_s10482_004_1729_x crossref_primary_10_1039_c2ob26553b crossref_primary_10_1111_j_1740_0929_2011_00915_x crossref_primary_10_1186_s13578_023_01044_0 crossref_primary_10_1039_c3ra42122h crossref_primary_10_1292_jvms_67_1243 crossref_primary_10_2329_perio_63_143 crossref_primary_10_1271_bbb_67_1996 crossref_primary_10_1002__SICI_1099_1573_200003_14_2_144__AID_PTR633_3_0_CO_2_Y crossref_primary_10_3762_bjoc_11_236 crossref_primary_10_1177_095632020701800206 crossref_primary_10_1515_HF_2007_033 crossref_primary_10_1007_s10886_007_9368_0 crossref_primary_10_3390_medicines8060026 crossref_primary_10_2174_1389450124666230707144251 crossref_primary_10_1142_S0219633616500632 crossref_primary_10_1515_HF_2007_034 crossref_primary_10_1128_AAC_49_6_2519_2521_2005 crossref_primary_10_1556_ABiol_59_2008_3_8 crossref_primary_10_1248_bpb_27_1666 crossref_primary_10_1007_s11172_016_1607_5 crossref_primary_10_1016_S0031_9422_02_00352_7 crossref_primary_10_1111_j_1742_7843_2005_pto_214_x |
ContentType | Journal Article |
Copyright | The Pharmaceutical Society of Japan 1999 INIST-CNRS Copyright Japan Science and Technology Agency 1999 |
Copyright_xml | – notice: The Pharmaceutical Society of Japan – notice: 1999 INIST-CNRS – notice: Copyright Japan Science and Technology Agency 1999 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7QR 7TK 7U9 8FD FR3 H94 P64 7X8 |
DOI | 10.1248/bpb.22.990 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Virology and AIDS Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5215 |
EndPage | 993 |
ExternalDocumentID | 3120430271 10_1248_bpb_22_990 10513629 1993847 article_bpb1993_22_9_22_9_990_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 2WC 53G 5GY 6J9 AAUGY ACGFO ACIWK ACPRK ADBBV AENEX AFFNX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P GX1 HH5 JSF JSH KQ8 OK1 P2P RJT RZJ TKC TR2 VH1 X7M ZXP 1CY 23N ABTAH BKOMP IQODW JMI MOJWN XSB ZY4 ABJNI CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7QR 7TK 7U9 8FD FR3 H94 P64 7X8 |
ID | FETCH-LOGICAL-c502t-51b24a6568f7a8a6302dd3c8fde25acecc020eff12b37b1221ea80905ae41093 |
ISSN | 0918-6158 |
IngestDate | Sat Aug 17 03:43:41 EDT 2024 Thu Oct 10 18:32:45 EDT 2024 Fri Aug 23 01:03:03 EDT 2024 Sat Sep 28 08:33:01 EDT 2024 Sun Oct 29 17:09:15 EDT 2023 Thu Aug 17 20:30:00 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Drug susceptibility test Enzyme Pharmacognosy Metalloendopeptidases In vitro Medicinal plant Peptidases Antifungal agent Staphylococcus epidermidis Thuja plicata Gymnospermae Minimum inhibitory concentration Plant origin Bacteria Hydrolases Micrococcales Coniferales Micrococcaceae Spermatophyta Activity spectrum Antibacterial agent Mechanism of action Comparative study |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c502t-51b24a6568f7a8a6302dd3c8fde25acecc020eff12b37b1221ea80905ae41093 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/bpb1993/22/9/22_9_990/_article/-char/en |
PMID | 10513629 |
PQID | 1449183107 |
PQPubID | 1966364 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_70825355 proquest_journals_1449183107 crossref_primary_10_1248_bpb_22_990 pubmed_primary_10513629 pascalfrancis_primary_1993847 jstage_primary_article_bpb1993_22_9_22_9_990_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1999-09-01 |
PublicationDateYYYYMMDD | 1999-09-01 |
PublicationDate_xml | – month: 09 year: 1999 text: 1999-09-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Biological & pharmaceutical bulletin |
PublicationTitleAlternate | Biol Pharm Bull |
PublicationYear | 1999 |
Publisher | The Pharmaceutical Society of Japan Maruzen Japan Science and Technology Agency |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Maruzen – name: Japan Science and Technology Agency |
References | 6) Inamori Y., Nishiguchi K., Matsuo N., Tsujibo H., Baba K., Ishida N., Chem. Pharm. Bull., 39, 2378-2381 (1991). 19) Oreal Cosmetic K.K., Japan. Kokai Tokkyo Koho, JP 81 147 705 [Chem. Abstr., 111, 148977y (1982)]. 16) Inamori Y., Muro C., Sajima E., Katagiri M., Okamoto Y., Tanaka H., Sakagami Y., Tsujibo H., Biosci. Biotech. Biochem., 61, 890-892 (1997). 2) Tada T., Nakatsuka T., Mokuzai Gakkaishi, 14, 344-345 (1968). 7) Inamori Y., Tsujibo H., Ohishi H., Ishii F., Mizugaki M., Aso H., Ishida N., Biol. Pharm. Bull., 16, 521-523 (1993). 15) Komiyama T., Aoyagi T., Takeuchi T., Umezawa H., Biochem. Biophys. Res. Commun., 65, 352-357 (1975). 22) Saito K. Ootomo Y., Okabe T., Japan. Kokai Tokkyo Koho, JP 01 90 103 [Chem. Abstr., 111, 148877x (1989)]. 12) Nozoe T., Takase K., Ogata M., Chem. Ind. (London), 1957, 1070 8) Borchardt R.T., J. Med. Chem., 16, 377-382 (1973). 5) Shibasaki I., Terui G., J. Ferment. Technol., 33, 216-223 (1955). 9) Mizutani Y., Yoshizato M., Maki Y., Nippon Yakurigaku Zasshi, 55, 1061-1064 (1959). 20) Katagiri Y., J. Jpn. Soc. Int. Med., 44, 32-40 (1955). 1) Nozoe T., Bull. Chem. Soc. Jpn., 11, 295-298 (1936). 11) Hori H., Nagai H., "Collagen Metabolism and Diseases," Kodansha, Tokyo, 1982. 3) Erdltman H., Gripenberg J., Nature (London), 161, 179 (1948). 10) Dikov M.M., Springman E.B., Yeola S., Serafin W.E., J. Biol. Chem., 269, 25897-25904 (1994). 13) Petra E., Methods Enzymol., 19, 460-503 (1970). 4) Okazaki K., Homma A., J. Pharm. Soc. Jpn., 74, 174-176 (1953). 17) Sasaki I., Tamura U., Japan. Kokai Tokkyo Koho, JP 63 188 69 [Chem. Abstr., 111, 102562n (1989)]. 14) Mandl I., Maclennon J.D., Howes E.L., Robert H.D., Sohler A., J. Clin. Invest., 32, 1323-1329 (1953). 18) Oreal Cosmetic K.K., Japan. Kokai Tokkyo Koho, JP 81 147 704 [Chem. Abstr., 111, 148977y (1982)]. 21) Ootomo Y, Okabe T., Saito K., Japan. Kokai Tokkyo Koho, JP 01 90 104 [Chem. Abstr., 111, 148877y (1989)]. |
References_xml | |
SSID | ssj0007023 |
Score | 1.8707024 |
Snippet | γ-Thujaplicin, β-dolabrin and hinokitiol(β-thujaplicin), hinokitiol-related compounds isolated from the wood of Thujopsis dolabrata S. and Z. hondai MAK have... Gamma-thujaplicin, beta-dolabrin and hinokitiol(beta-thujaplicin), hinokitiol-related compounds isolated from the wood of Thujopsis dolabrata S. and Z. hondai... |
SourceID | proquest crossref pubmed pascalfrancis jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 990 |
SubjectTerms | Anti-Bacterial Agents Anti-Infective Agents - pharmacology antimicrobial activity Bacteria - drug effects Biological and medical sciences Carboxypeptidases - antagonists & inhibitors Carboxypeptidases A Cycadopsida - chemistry General pharmacology hinokitiol hinokitiol-related compound Matrix Metalloproteinase Inhibitors Medical sciences Metalloendopeptidases - antagonists & inhibitors metalloprotease inhibition Monoterpenes Penicillium - drug effects Pharmacognosy. Homeopathy. Health food Pharmacology. Drug treatments Protease Inhibitors - pharmacology Thermolysin - antagonists & inhibitors Tropolone - analogs & derivatives Tropolone - chemistry Tropolone - pharmacology β-dolabrin γ-thujaplicin |
Title | Antimicrobial Activity and Metalloprotease Inhibition of Hinokitiol-Related Compounds, the Constituents of Thujopsis dolabrata S. and Z. hondai MAK |
URI | https://www.jstage.jst.go.jp/article/bpb1993/22/9/22_9_990/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/10513629 https://www.proquest.com/docview/1449183107 https://search.proquest.com/docview/70825355 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Biological and Pharmaceutical Bulletin, 1999/09/15, Vol.22(9), pp.990-993 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF61BQkkhCClEGhhJVAvqY29sWNb4uK2qZKmTVDjSlUvlp-yC7WjxDnkd_CHmd211zYVCA5crMj7kvPNzM7M7swg9Mky9EHYD32JhP1A0szAlHw_NqUANlffgy2aZ_sczY3pjXk61IZb21UJxfrdf0Ua3gHWNHL2H9AWk8IL-A2YwxNQh-df4W5nRXqfsvRK9N8PyuoQ7D5FVNBjdpaaATYvkA1J6qeVyjhKM-rKTfPvErshR12_ICxo2SWGdcEq3PG7BVF5ecZJ1nf5guY0CcFEBsO78HpzmS12K_eSHOz9tHdpT1pHx6mQt5TsFknLqe4304FTkp3al7OrMdsp8lWSJum3XHiFRuPpbGRf2dy1vRENzvz6fHw8Y9tquqTDhC95Yh-z-58On2yZ124PnirBaro9zkGVqOUf_az6KKJns7DVpq9TNcFG5jni5YhL-r5mgBXOY0mrrYCQBslbDblu8ZqmD_YbotEYCn_hy4TIZad2Uu_pzD27vrhwneGN027lSoRKg5MVQtMgPCIgLGn9h9PxRGgThsJKFIpPKFPswsKf62VbStXjO7AraMKIZwtvBcjFvELL700opko5L9Dz0gbCNifel2gryjpo1868Ir_f4EPMbiWz_7iDnpxUFQk76PArp5XNEXbqsMHVERsiMrBvdtGPFhPgigkwAIh_YQJcMwHOY_yQCbBggiMMLICbLEBHCBbAggXwXGZL3cqYswAGFniFnLOhczKSyuojUqArpJB01SeaB-aOGRue6Q0ApBDkmRmHEdGBLYIALK0ojlXi9w1fJUSNPFOxFN2LNJqjbQ_tZHkWvUE4igeBrgaayYraeIo_GFhmSIgBUhEmi7voY4Weu-A5ZlxqmwPGLmDsEuICxl30hQMr-pQyhvah13BZP_6A7qKVRm-CYOyigxY51CvBUFBRu2i_Ig-3FGcrV9U0oDuwAKH5g2gG1OmpopdF-XrlGtTJBFZLF73mRNX4Bl0F_dh6--ep36GnNYPvo51iuY4O0PYqXL9nrPATP4sFeA |
link.rule.ids | 315,782,786,27934,27935 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+Activity+and+Metalloprotease+Inhibition+of+Hinokitiol-Related+Compounds%2C+the+Constituents+of+Thujopsis+dolabrata+S.+and+Z.+hondai+MAK&rft.jtitle=Biological+%26+pharmaceutical+bulletin&rft.au=INAMORI%2C+Yoshihiko&rft.au=SHINOHARA%2C+Sayo&rft.au=TSUJIBO%2C+Hiroshi&rft.au=OKABE%2C+Toshihiro&rft.date=1999-09-01&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0918-6158&rft.eissn=1347-5215&rft.volume=22&rft.issue=9&rft.spage=990&rft_id=info:doi/10.1248%2Fbpb.22.990&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3120430271 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-6158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-6158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-6158&client=summon |